Sunshine Biopharma Files DEF 14C
Sunshine Biopharma filed a DEF 14C. The headline gives Oct. 30 as a date; the filing date is reported as October 27, 20.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
8 results loaded, newest first. End of these results.
Sunshine Biopharma filed a DEF 14C. The headline gives Oct. 30 as a date; the filing date is reported as October 27, 20.
For best results when printing this announcement, please click on link below: LandBridge Announces Completion of Conversion and Redomestication in Texas LandBridge Corporation (NYSE: LB; NYSE Texas: LB) (“LandBridge” or the “Company”) today announced that it has completed its previously announced conversion and redomes
Cemtrex said its reincorporation from Delaware to Nevada became effective on Oct. 7. The company said it continues under the same business, management and assets, with shares and listings unchanged.
Stagewise Strategies said it entered into a share exchange agreement to acquire 99.99999012% of TEG SPV in exchange for 183,098,434 shares of common stock. The company said the closing is subject to customary conditions, including at least $18 million of concurrent financing.
Greenpro Capital Corp. approves a 1-for-10 reverse stock split, effective on or about July 26, to increase the per-share trading price of its common stock.
Principal Variable Contracts Funds Inc submits regulatory filing with the SEC. The filing provides information on the company's contracts and agreements.
Alpha Modus Holdings submits regulatory filing with SEC. Filing details not specified.
Company files DEF 14C form with SEC